Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeEXECUTIVESEric Hargan Joins Alio Board of Directors

Eric Hargan Joins Alio Board of Directors

March 30, 2021

Eric Hargan will join the Alio Board of Directors as an Observer effective March 2021.

Alio has achieved a number of important milestones in the last several months, culminating in Hargan’s addition to the board.

Eric Hargan brings 25 years of legal and healthcare expertise and is nationally recognized for his former role as United States Deputy Secretary of Health and Human Services (HHS) from October 2017 to January 2021.  He has played an instrumental role in driving innovation in the dialysis market, from realigning incentives to enable value-based arrangements between providers and digital health companies to enabling the availability of more breakthrough devices.

Hargan was also critical to the creation of The Kidney Innovation Accelerator (KidneyX), a public-private partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. ASN recognized Hargan’s work on KidneyX and the HHS Kidney Health Initiative with its President’s Medal in 2019.

Prior to his role as US Deputy Security of the HHS, Eric Hargan served in the private sector as a partner at Greenberg Traurig and McDermott Will & Emery. From 2003-2005, he served as Deputy General Counsel of HHS for the George W. Bush administration, eventually serving as Acting Deputy Secretary of HHS. Hargan began his career in corporate law at Winston & Strawn.

“Hargan’s deep expertise in the regulatory process, as well as his passion for innovation, make him an excellent addition to our board,” said David Kuraguntla, Alio’s Co-Founder and CEO. “Working in and around healthcare in a variety of capacities has only reinforced the importance of chronic condition management to Mr. Hargan. He recognizes the value of supporting a patient in better maintaining and monitoring their condition.”

Alio’s technology has been honed and advanced through a number of strategic partnerships, including Intermountain Healthcare. Rather than repurposing off-the-shelf sensors and technology, Alio has created their proprietary technology with the chronic condition community in mind. Each new application has allowed Alio to better understand the reach, scope and scale of what they can accomplish in the remote patient monitoring world. Hargan’s expertise, particularly in remote patient monitoring and forward-thinking reimbursement practices, will be essential in guiding Alio at this critical inflection point.

“Without products like Alio’s SmartPatch, we won’t be able to rethink our approach to managing chronic conditions, particularly for the more vulnerable patient populations,” said Eric Hargan, former Deputy Secretary of Health and Human Services. “We need to do more to deliver the right level of care at the right place and right time. If you look at the way we have approached cancer management, we’ve come so far but comparatively, dialysis care has hardly changed over the last forty years. It’s time we bring to market solutions that reimagine, improve and progress our management of kidney conditions.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy